Eva A Mistry1, Stephan A Mayer2, Pooja Khatri3. 1. Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio. Electronic address: esamin87@gmail.com. 2. Department of Neurology, Henry Ford Health System, Detroit, Michigan. 3. Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio.
Abstract
BACKGROUND: It is unclear what factors providers take into account to determine the target blood pressure (BP) after mechanical thrombectomy (MT) in patients who had acute ischemic stroke. We aimed to understand practice patterns of post-MT BP management across institutions in the United States. METHODS: We surveyed StrokeNet institutions providing MT and post-MT care with an online questionnaire, designed to understand institutional post-MT BP management practices. RESULTS: Of 131 potential institutions, 58 completed the survey. The majority of institutions target systolic BP (SBP, n = 53, 91%) during the first 24 hours post-MT (n = 32, 55%) using nicardipine as a first-line agent (n = 43, 74%). At most institutions, BP management is determined by a team of physicians in a collaborative fashion (n = 30, 52%) and individualized on a case-by-case basis (n = 39, 67%) after taking the reperfusion status into account (n = 42, 72%). In patients with successful reperfusion, 36% (n = 21) of the institutions target SBP in the range of 120-139 mm Hg, 21% (n = 12) target 140-159 mm Hg, and 28% (n = 16) would accept any value less than or equal to 180 mm Hg. In patients with unsuccessful reperfusion, 43% (n = 25) would accept any SBP value less than or equal to 180 mm Hg and 10% (n = 6) would target SBP less than or equal to 220 mm Hg. CONCLUSIONS: We found that majority of the institutions do not have a standardized protocol for post-MT BP management. There was interinstitutional heterogeneity in the preferred target of SBP post-MT and most institutions target values of SBP lower than 180 mm Hg in post-MT patients. Prospective data and randomized control trial are needed to identify the optimal target BP.
BACKGROUND: It is unclear what factors providers take into account to determine the target blood pressure (BP) after mechanical thrombectomy (MT) in patients who had acute ischemic stroke. We aimed to understand practice patterns of post-MT BP management across institutions in the United States. METHODS: We surveyed StrokeNet institutions providing MT and post-MT care with an online questionnaire, designed to understand institutional post-MT BP management practices. RESULTS: Of 131 potential institutions, 58 completed the survey. The majority of institutions target systolic BP (SBP, n = 53, 91%) during the first 24 hours post-MT (n = 32, 55%) using nicardipine as a first-line agent (n = 43, 74%). At most institutions, BP management is determined by a team of physicians in a collaborative fashion (n = 30, 52%) and individualized on a case-by-case basis (n = 39, 67%) after taking the reperfusion status into account (n = 42, 72%). In patients with successful reperfusion, 36% (n = 21) of the institutions target SBP in the range of 120-139 mm Hg, 21% (n = 12) target 140-159 mm Hg, and 28% (n = 16) would accept any value less than or equal to 180 mm Hg. In patients with unsuccessful reperfusion, 43% (n = 25) would accept any SBP value less than or equal to 180 mm Hg and 10% (n = 6) would target SBP less than or equal to 220 mm Hg. CONCLUSIONS: We found that majority of the institutions do not have a standardized protocol for post-MT BP management. There was interinstitutional heterogeneity in the preferred target of SBP post-MT and most institutions target values of SBP lower than 180 mm Hg in post-MT patients. Prospective data and randomized control trial are needed to identify the optimal target BP.
Authors: Nils H Petersen; Andrew Silverman; Sumita M Strander; Sreeja Kodali; Anson Wang; Lauren H Sansing; Joseph L Schindler; Guido J Falcone; Emily J Gilmore; Adam S Jasne; Branden Cord; Ryan M Hebert; Michele Johnson; Charles C Matouk; Kevin N Sheth Journal: Stroke Date: 2020-02-12 Impact factor: 7.914
Authors: Mohammad Anadani; Adam S Arthur; Ali Alawieh; Yser Orabi; Andrei Alexandrov; Nitin Goyal; Marios-Nikos Psychogios; Ilko Maier; Joon-Tae Kim; Saleh G Keyrouz; Adam de Havenon; Nils H Petersen; Abhi Pandhi; Christa B Swisher; Ovais Inamullah; Jan Liman; Sreeja Kodali; James A Giles; Michelle Allen; Stacey Q Wolfe; Georgios Tsivgoulis; Bradley A Cagle; Chesney S Oravec; Benjamin Gory; Pierre De Marini; Peter Kan; Shareena Rahman; Sébastien Richard; Fábio A Nascimento; Alejandro Spiotta Journal: J Neurointerv Surg Date: 2019-12-05 Impact factor: 5.836
Authors: Nils H Petersen; Sreeja Kodali; Can Meng; Fangyong Li; Cindy Khanh Nguyen; Krithika U Peshwe; Sumita Strander; Andrew Silverman; Alexandra Kimmel; Anson Wang; Mohammad Anadani; Eyad Almallouhi; Alejandro M Spiotta; Joon-Tae Kim; James A Giles; Salah G Keyrouz; Mudassir Farooqui; Cynthia Zevallos; Ilko L Maier; Marios-Nikos Psychogios; Jan Liman; Nolwenn Riou-Comte; Sébastien Richard; Benjamin Gory; Stacey Quintero Wolfe; Patrick A Brown; Kyle M Fargen; Eva A Mistry; Hiba Fakhri; Akshitkumar M Mistry; Ka-Ho Wong; Adam de Havenon; Fábio A Nascimento; Peter Kan; Charles Matouk; Santiago Ortega-Gutiérrez; Kevin N Sheth Journal: Stroke Date: 2021-11-16 Impact factor: 7.914
Authors: Eva A Mistry; Heidi Sucharew; Akshitkumar M Mistry; Tapan Mehta; Niraj Arora; Amy K Starosciak; Felipe De Los Rios La Rosa; James Ernest Siegler; Natasha R Barnhill; Kishan Patel; Salman Assad; Amjad Tarboosh; Katarina Dakay; Sanjana Salwi; Aurora S Cruz; Jeffrey Wagner; Enzo Fortuny; Alicia Bennett; Robert F James; Bharathi Jagadeesan; Christopher Streib; Kristine O'Phelan; Scott E Kasner; Stewart A Weber; Rohan Chitale; John J Volpi; Stephan Mayer; Shadi Yaghi; Mahesh V Jayaraman; Pooja Khatri Journal: Stroke Date: 2019-10-07 Impact factor: 7.914
Authors: Adam de Havenon; Nils Petersen; Ali Sultan-Qurraie; Matthew Alexander; Shadi Yaghi; Min Park; Ramesh Grandhi; Eva Mistry Journal: Semin Neurol Date: 2021-01-20 Impact factor: 3.420
Authors: Mohammad Anadani; Adam de Havenon; Shadi Yaghi; Tapan Mehta; Niraj Arora; Amy Kathryn Starosciak; Felipe De Los Rios La Rosa; James Siegler; Akshitkumar M Mistry; Rohan Chitale; Alejandro M Spiotta; Georgios Tsivgoulis; Pooja Khatri; Eva A Mistry Journal: J Neurointerv Surg Date: 2020-09-03 Impact factor: 8.572